| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.549 | 0.014 | 0.549 | Calpain 2 inhibitor | 0.494 0.026 DBMET00965 | ||
| 0.482 | 0.01 | 0.582 | Interleukin agonist | 0.582 0.005 DBMET00965 | DBMET00965 | |
| 0.455 | 0.007 | 0.779 | Alpha-N-acetylglucosaminidase inhibitor | 0.779 0.002 DBMET00965 | DBMET00965 | |
| 0.43 | 0.014 | 0.43 | Transcription factor STAT3 inhibitor | 0.391 0.02 DBMET00965 | ||
| 0.409 | 0.017 | 0.409 | Transcription factor STAT inhibitor | 0.399 0.019 DBMET00965 | ||
| 0.395 | 0.01 | 0.395 | Calpain inhibitor | 0.356 0.016 DBMET00965 | ||
| 0.409 | 0.029 | 0.494 | Interleukin antagonist | 0.494 0.02 DBMET00965 | DBMET00965 | |
| 0.402 | 0.049 | 0.436 | Immunostimulant | 0.436 0.04 DBMET00965 | DBMET00965 | |
| 0.335 | 0.007 | 0.335 | Nav1.3 sodium channel blocker | 0.25 0.014 DBMET00965 | ||
| 0.339 | 0.025 | 0.339 | Growth hormone agonist | 0.269 0.039 DBMET00965 | ||
| 0.326 | 0.017 | 0.429 | Peptidyltransferase inhibitor | 0.429 0.005 DBMET00965 | DBMET00965 | |
| 0.291 | 0.009 | 0.291 | Carbonic anhydrase XV inhibitor | 0.231 0.014 DBMET00965 | ||
| 0.314 | 0.032 | 0.314 | Ca(v)3.3 blocker | 0.3 0.042 DBMET00965 | ||
| 0.288 | 0.011 | 0.288 | Proteasome inhibitor | 0.273 0.013 DBMET00965 | ||
| 0.315 | 0.045 | 0.478 | Superoxide dismutase inhibitor | 0.478 0.015 DBMET00965 | DBMET00965 | |
| 0.262 | 0.007 | 0.295 | Toll-Like receptor 2 antagonist | 0.295 0.005 DBMET00965 | DBMET00965 | |
| 0.275 | 0.022 | 0.276 | Thiol protease inhibitor | 0.276 0.022 DBMET00965 | DBMET00965 | |
| 0.303 | 0.056 | 0.348 | Insulysin inhibitor | 0.348 0.035 DBMET00965 | DBMET00965 | |
| 0.292 | 0.052 | 0.407 | Angiogenesis stimulant | 0.407 0.021 DBMET00965 | DBMET00965 | |
| 0.273 | 0.036 | 0.313 | Neuropeptide Y2 antagonist | 0.313 0.014 DBMET00965 | DBMET00965 | |
| 0.314 | 0.077 | 0.377 | Apoptosis antagonist | 0.377 0.045 DBMET00965 | DBMET00965 | |
| 0.352 | 0.116 | 0.352 | Calcium channel L-type activator | 0.248 0.207 DBMET00965 | ||
| 0.226 | 0.012 | 0.226 | Neuropeptide Y1 antagonist | 0.203 0.018 DBMET00965 | ||
| 0.216 | 0.007 | 0.216 | Caspase 3 inhibitor | 0.211 0.008 DBMET00965 | ||
| 0.237 | 0.033 | 0.257 | 3C-like protease (Human coronavirus) inhibitor | 0.257 0.024 DBMET00965 | DBMET00965 | |
| 0.206 | 0.004 | 0.206 | Glutamate (mGluR7) agonist | 0.165 0.008 DBMET00965 | ||
| 0.2 | 0.01 | 0.23 | Sphingomyelinase inhibitor | 0.23 0.005 DBMET00965 | DBMET00965 | |
| 0.202 | 0.016 | 0.202 | Carbonic anhydrase III inhibitor | 0.174 0.021 DBMET00965 | ||
| 0.274 | 0.094 | 0.359 | Interleukin 2 agonist | 0.359 0.042 DBMET00965 | DBMET00965 | |
| 0.283 | 0.106 | 0.357 | Vasodilator, peripheral | 0.357 0.071 DBMET00965 | DBMET00965 | |
| 0.18 | 0.007 | 0.18 | Glutathione S-transferase inhibitor | 0.176 0.008 DBMET00965 | ||
| 0.183 | 0.017 | 0.184 | Vanilloid 1 agonist | 0.184 0.017 DBMET00965 | DBMET00965 | |
| 0.171 | 0.006 | 0.244 | NMDA receptor agonist | 0.244 0.004 DBMET00965 | DBMET00965 | |
| 0.167 | 0.01 | 0.209 | Toll-Like receptor 2 agonist | 0.209 0.007 DBMET00965 | DBMET00965 | |
| 0.161 | 0.004 | 0.187 | NMDA receptor glycine site agonist | 0.187 0.003 DBMET00965 | DBMET00965 | |
| 0.218 | 0.062 | 0.218 | Nitric-oxide synthase stimulant | 0.204 0.082 DBMET00965 | ||
| 0.183 | 0.028 | 0.222 | Cathepsin H inhibitor | 0.222 0.018 DBMET00965 | DBMET00965 | |
| 0.164 | 0.013 | 0.164 | Interleukin 1 beta converting enzyme inhibitor | 0.159 0.014 DBMET00965 | ||
| 0.174 | 0.026 | 0.192 | Falcipain 3 inhibitor | 0.192 0.02 DBMET00965 | DBMET00965 | |
| 0.182 | 0.038 | 0.239 | Histone deacetylase SIRT1 inhibitor | 0.239 0.02 DBMET00965 | DBMET00965 | |
| 0.165 | 0.022 | 0.199 | Heat shock protein 70 antagonist | 0.199 0.006 DBMET00965 | DBMET00965 | |
| 0.187 | 0.049 | 0.187 | MAP kinase kinase 5 inhibitor | 0.174 0.076 DBMET00965 | ||
| 0.147 | 0.01 | 0.17 | 3C-Like protease (SARS coronavirus) inhibitor | 0.17 0.006 DBMET00965 | DBMET00965 | |
| 0.164 | 0.028 | 0.164 | Nav1.1 sodium channel blocker | 0.114 0.053 DBMET00965 | ||
| 0.26 | 0.124 | 0.26 | Vasodilator, coronary | 0.237 0.148 DBMET00965 | ||
| 0.176 | 0.044 | 0.204 | Hemostatic | 0.204 0.031 DBMET00965 | DBMET00965 | |
| 0.181 | 0.049 | 0.224 | Neurotensin receptor agonist | 0.224 0.026 DBMET00965 | DBMET00965 | |
| 0.298 | 0.167 | 0.332 | 5 Hydroxytryptamine release inhibitor | 0.332 0.132 DBMET00965 | DBMET00965 | |
| 0.135 | 0.007 | 0.135 | Secretase beta inhibitor | 0.115 0.012 DBMET00965 | ||
| 0.179 | 0.053 | 0.204 | Catenin beta inhibitor | 0.204 0.029 DBMET00965 | DBMET00965 | |
| 0.155 | 0.029 | 0.165 | Papain-like protease (SARS coronavirus) inhibitor | 0.165 0.023 DBMET00965 | DBMET00965 | |
| 0.133 | 0.008 | 0.133 | Protease 3C (Human rhinovirus) inhibitor | 0.123 0.009 DBMET00965 | ||
| 0.179 | 0.058 | 0.179 | ATPase inhibitor | 0.141 0.118 DBMET00965 | ||
| 0.161 | 0.04 | 0.166 | Cyclooxygenase 3 inhibitor | 0.166 0.036 DBMET00965 | DBMET00965 | |
| 0.131 | 0.01 | 0.131 | Cathepsin D inhibitor | 0.113 0.014 DBMET00965 | ||
| 0.179 | 0.062 | 0.217 | Anticoagulant | 0.217 0.047 DBMET00965 | DBMET00965 | |
| 0.148 | 0.031 | 0.158 | Protease inhibitor | 0.158 0.026 DBMET00965 | DBMET00965 | |
| 0.135 | 0.021 | 0.142 | Chymotrypsin inhibitor | 0.142 0.019 DBMET00965 | DBMET00965 | |
| 0.142 | 0.028 | 0.214 | Catalase inhibitor | 0.214 0.013 DBMET00965 | DBMET00965 | |
| 0.218 | 0.107 | 0.267 | Tyrosine 3 hydroxylase inhibitor | 0.267 0.053 DBMET00965 | DBMET00965 | |
| 0.146 | 0.035 | 0.17 | Mucolytic | 0.17 0.022 DBMET00965 | DBMET00965 | |
| 0.147 | 0.04 | 0.147 | Calcium channel N-type blocker | 0.118 0.065 DBMET00965 | ||
| 0.149 | 0.047 | 0.183 | Antibacterial (Helicobacter pylori) | 0.183 0.027 DBMET00965 | DBMET00965 | |
| 0.147 | 0.046 | 0.182 | Histone deacetylase class III inhibitor | 0.182 0.025 DBMET00965 | DBMET00965 | |
| 0.169 | 0.069 | 0.418 | Peroxidase inhibitor | 0.418 0.018 DBMET00965 | DBMET00965 | |
| 0.122 | 0.022 | 0.146 | Neuropeptide agonist | 0.146 0.014 DBMET00965 | DBMET00965 | |
| 0.121 | 0.022 | 0.289 | Hematopoietic | 0.289 0.005 DBMET00965 | DBMET00965 | |
| 0.109 | 0.009 | 0.12 | Kallikrein inhibitor | 0.12 0.008 DBMET00965 | DBMET00965 | |
| 0.23 | 0.132 | 0.339 | Immunomodulator | 0.339 0.063 DBMET00965 | DBMET00965 | |
| 0.235 | 0.138 | 0.275 | Transcription factor NF kappa B inhibitor | 0.275 0.11 DBMET00965 | DBMET00965 | |
| 0.207 | 0.113 | 0.267 | DNA synthesis inhibitor | 0.267 0.057 DBMET00965 | DBMET00965 | |
| 0.122 | 0.028 | 0.122 | Metalloproteinase-2 inhibitor | 0.114 0.032 DBMET00965 | ||
| 0.115 | 0.021 | 0.115 | Vanilloid agonist | 0.107 0.027 DBMET00965 | ||
| 0.095 | 0.005 | 0.095 | Melatonin agonist | 0.063 0.007 DBMET00965 | ||
| 0.125 | 0.035 | 0.133 | Factor V inhibitor | 0.133 0.028 DBMET00965 | DBMET00965 | |
| 0.182 | 0.093 | 0.234 | Insulin sensitizer | 0.234 0.044 DBMET00965 | DBMET00965 | |
| 0.194 | 0.104 | 0.194 | Antiamyloidogenic | 0.178 0.116 DBMET00965 | ||
| 0.151 | 0.062 | 0.177 | Adenylate cyclase stimulant | 0.177 0.028 DBMET00965 | DBMET00965 | |
| 0.093 | 0.004 | 0.093 | GHS receptor antagonist | 0.047 0.008 DBMET00965 | ||
| 0.108 | 0.02 | 0.138 | Neutrophil collagenase inhibitor | 0.138 0.014 DBMET00965 | DBMET00965 | |
| 0.098 | 0.012 | 0.098 | Factor VIIa inhibitor | 0.096 0.012 DBMET00965 | ||
| 0.147 | 0.061 | 0.147 | Calcium channel blocker | |||
| 0.114 | 0.032 | 0.114 | Carbonic anhydrase VI inhibitor | 0.102 0.038 DBMET00965 | ||
| 0.094 | 0.012 | 0.105 | Gonadotropin-releasing hormone receptor agonist | 0.105 0.009 DBMET00965 | DBMET00965 | |
| 0.11 | 0.029 | 0.122 | Factor XII inhibitor | 0.122 0.023 DBMET00965 | DBMET00965 | |
| 0.127 | 0.046 | 0.159 | Expectorant | 0.159 0.032 DBMET00965 | DBMET00965 | |
| 0.084 | 0.005 | 0.084 | Melatonin 1 agonist | 0.068 0.005 DBMET00965 | ||
| 0.084 | 0.005 | 0.084 | Growth hormone releasing factor agonist | 0.059 0.01 DBMET00965 | ||
| 0.093 | 0.014 | 0.124 | Kallikrein 1 inhibitor | 0.124 0.009 DBMET00965 | DBMET00965 | |
| 0.127 | 0.049 | 0.127 | Calcium channel (voltage-sensitive) blocker | |||
| 0.083 | 0.005 | 0.097 | Immunoglobulin Fc receptor antagonist | 0.097 0.004 DBMET00965 | DBMET00965 | |
| 0.08 | 0.003 | 0.123 | Protease (Human cytomegalovirus) inhibitor | 0.123 0.003 DBMET00965 | DBMET00965 | |
| 0.093 | 0.018 | 0.093 | Collagenase 3 inhibitor | 0.085 0.021 DBMET00965 | ||
| 0.17 | 0.095 | 0.17 | Amyloid beta aggregation inhibitor | 0.152 0.106 DBMET00965 | ||
| 0.104 | 0.03 | 0.104 | Metalloproteinase-9 inhibitor | 0.095 0.035 DBMET00965 | ||
| 0.092 | 0.019 | 0.106 | Human rhinovirus A protease inhibitor | 0.106 0.015 DBMET00965 | DBMET00965 | |
| 0.092 | 0.019 | 0.092 | Cathepsin B inhibitor | 0.08 0.024 DBMET00965 | ||
| 0.101 | 0.028 | 0.101 | Caspase 7 inhibitor | |||
| 0.081 | 0.009 | 0.081 | Growth hormone secretagogue receptor antagonist | 0.055 0.016 DBMET00965 | ||
| 0.084 | 0.014 | 0.084 | Metalloproteinase-3 inhibitor | 0.068 0.02 DBMET00965 | ||
| 0.147 | 0.077 | 0.163 | Phospholipase A2 inhibitor | 0.163 0.064 DBMET00965 | DBMET00965 | |
| 0.093 | 0.024 | 0.096 | Elastase 1 inhibitor | 0.096 0.022 DBMET00965 | DBMET00965 | |
| 0.075 | 0.006 | 0.084 | Caspase 2 inhibitor | 0.084 0.005 DBMET00965 | DBMET00965 | |
| 0.088 | 0.02 | 0.117 | Neuraminidase inhibitor | 0.117 0.01 DBMET00965 | DBMET00965 | |
| 0.104 | 0.036 | 0.104 | Carbonic anhydrase XIII inhibitor | 0.078 0.051 DBMET00965 | ||
| 0.073 | 0.005 | 0.073 | Melatonin antagonist | 0.041 0.009 DBMET00965 | ||
| 0.072 | 0.005 | 0.072 | Melatonin 2 agonist | 0.063 0.007 DBMET00965 | ||
| 0.126 | 0.062 | 0.126 | DNA repair enzyme inhibitor | 0.119 0.075 DBMET00965 | ||
| 0.12 | 0.057 | 0.12 | Photosensitizer | 0.109 0.073 DBMET00965 | ||
| 0.148 | 0.085 | 0.169 | Melanin inhibitor | 0.169 0.06 DBMET00965 | DBMET00965 | |
| 0.067 | 0.005 | 0.067 | Growth hormone release promoting | 0.037 0.008 DBMET00965 | ||
| 0.109 | 0.048 | 0.122 | Nitric-oxide synthase inhibitor | 0.122 0.037 DBMET00965 | DBMET00965 | |
| 0.176 | 0.116 | 0.176 | 5 Hydroxytryptamine 3E antagonist | 0.174 0.122 DBMET00965 | ||
| 0.115 | 0.056 | 0.115 | Acetylcholine release stimulant | |||
| 0.145 | 0.086 | 0.271 | Thrombolytic | 0.271 0.029 DBMET00965 | DBMET00965 | |
| 0.108 | 0.05 | 0.108 | Falcipain inhibitor | 0.101 0.054 DBMET00965 | ||
| 0.065 | 0.008 | 0.065 | Plasma kallikrein inhibitor | 0.052 0.011 DBMET00965 | ||
| 0.083 | 0.027 | 0.083 | Potassium channel (Tandem pore domain) blocker | 0.078 0.04 DBMET00965 | ||
| 0.06 | 0.005 | 0.06 | Melatonin receptor 1A agonist | 0.042 0.012 DBMET00965 | ||
| 0.069 | 0.015 | 0.069 | Leukocyte elastase inhibitor | 0.044 0.029 DBMET00965 | ||
| 0.064 | 0.01 | 0.075 | Neuraminidase (Influenza A) inhibitor | 0.075 0.006 DBMET00965 | DBMET00965 | |
| 0.063 | 0.01 | 0.063 | Plasmepsin II inhibitor | 0.047 0.02 DBMET00965 | ||
| 0.095 | 0.043 | 0.095 | Granulocyte macrophage colony stimulating factor agonist | 0.081 0.072 DBMET00965 | ||
| 0.09 | 0.038 | 0.11 | Interferon agonist | 0.11 0.022 DBMET00965 | DBMET00965 | |
| 0.085 | 0.034 | 0.087 | Matrix metalloproteinase inhibitor | 0.087 0.033 DBMET00965 | DBMET00965 | |
| 0.077 | 0.026 | 0.077 | Cathepsin L inhibitor | 0.068 0.031 DBMET00965 | ||
| 0.238 | 0.188 | 0.347 | Antibacterial | 0.347 0.104 DBMET00965 | DBMET00965 | |
| 0.063 | 0.013 | 0.123 | Gonadotropin-releasing hormone receptor antagonist | 0.123 0.005 DBMET00965 | DBMET00965 | |
| 0.066 | 0.017 | 0.067 | Vanilloid 2 antagonist | 0.067 0.016 DBMET00965 | DBMET00965 | |
| 0.074 | 0.026 | 0.079 | Cathepsin E inhibitor | 0.079 0.023 DBMET00965 | DBMET00965 | |
| 0.172 | 0.124 | 0.217 | Platelet antagonist | 0.217 0.09 DBMET00965 | DBMET00965 | |
| 0.088 | 0.04 | 0.088 | Ca(v)3.1 blocker | 0.087 0.042 DBMET00965 | ||
| 0.067 | 0.019 | 0.088 | Alpha-mannosidase inhibitor | 0.088 0.009 DBMET00965 | DBMET00965 | |
| 0.064 | 0.018 | 0.064 | HCV NS3/NS4A protease inhibitor | 0.06 0.021 DBMET00965 | ||
| 0.065 | 0.018 | 0.072 | Lysophosphatidic acid 3 receptor antagonist | 0.072 0.013 DBMET00965 | DBMET00965 | |
| 0.098 | 0.053 | 0.098 | Falcipain 2 inhibitor | 0.092 0.058 DBMET00965 | ||
| 0.083 | 0.038 | 0.088 | Thrombin inhibitor | 0.088 0.034 DBMET00965 | DBMET00965 | |
| 0.061 | 0.015 | 0.061 | CC chemokine 4 receptor antagonist | 0.055 0.021 DBMET00965 | ||
| 0.075 | 0.03 | 0.113 | Neuraminidase (influenza) inhibitor | 0.113 0.013 DBMET00965 | DBMET00965 | |
| 0.057 | 0.014 | 0.057 | Renin inhibitor | 0.04 0.023 DBMET00965 | ||
| 0.07 | 0.028 | 0.08 | Histone deacetylase SIRT3 inhibitor | 0.08 0.018 DBMET00965 | DBMET00965 | |
| 0.07 | 0.028 | 0.07 | Carbonic anhydrase VB inhibitor | 0.062 0.033 DBMET00965 | ||
| 0.159 | 0.118 | 0.159 | Anticonvulsant | 0.147 0.133 DBMET00965 | ||
| 0.049 | 0.008 | 0.049 | Plasmepsin I inhibitor | |||
| 0.079 | 0.038 | 0.079 | Carbonic anhydrase VA inhibitor | 0.071 0.045 DBMET00965 | ||
| 0.071 | 0.031 | 0.105 | Plasminogen activator inhibitor | 0.105 0.014 DBMET00965 | DBMET00965 | |
| 0.107 | 0.068 | 0.115 | Chelator | 0.115 0.059 DBMET00965 | DBMET00965 | |
| 0.085 | 0.046 | 0.108 | Somatostatin 1 agonist | 0.108 0.029 DBMET00965 | DBMET00965 | |
| 0.088 | 0.049 | 0.094 | Inducible nitric-oxide synthase inhibitor | 0.094 0.042 DBMET00965 | DBMET00965 | |
| 0.077 | 0.038 | 0.113 | Sirtuin 1 inhibitor | 0.113 0.017 DBMET00965 | DBMET00965 | |
| 0.079 | 0.041 | 0.079 | Calcium channel L-type blocker | |||
| 0.08 | 0.042 | 0.114 | GABA B receptor agonist | 0.114 0.009 DBMET00965 | DBMET00965 | |
| 0.103 | 0.065 | 0.103 | Toll-Like receptor 4 antagonist | |||
| 0.068 | 0.033 | 0.075 | Aminopeptidase microsomal inhibitor | 0.075 0.028 DBMET00965 | DBMET00965 | |
| 0.079 | 0.043 | 0.115 | Vanilloid 4 agonist | 0.115 0.009 DBMET00965 | DBMET00965 | |
| 0.062 | 0.026 | 0.065 | Protease activated receptor 1 antagonist | 0.065 0.024 DBMET00965 | DBMET00965 | |
| 0.064 | 0.029 | 0.064 | Matrix metalloproteinase (membrane-type) inhibitor | 0.058 0.034 DBMET00965 | ||
| 0.11 | 0.075 | 0.11 | Anesthetic local | |||
| 0.068 | 0.033 | 0.087 | Bombesin 1 receptor agonist | 0.087 0.022 DBMET00965 | DBMET00965 | |
| 0.119 | 0.085 | 0.142 | Nav1.2 sodium channel blocker | 0.142 0.062 DBMET00965 | DBMET00965 | |
| 0.063 | 0.029 | 0.063 | Matrix metalloproteinase 1 inhibitor | 0.062 0.03 DBMET00965 | ||
| 0.069 | 0.036 | 0.084 | Interferon inducer | 0.084 0.021 DBMET00965 | DBMET00965 | |
| 0.038 | 0.005 | 0.038 | Melatonin 1 antagonist | 0.021 0.01 DBMET00965 | ||
| 0.148 | 0.116 | 0.148 | Anesthetic general | 0.148 0.116 DBMET00965 | ||
| 0.05 | 0.019 | 0.068 | Neurokinin 2 agonist | 0.068 0.009 DBMET00965 | DBMET00965 | |
| 0.04 | 0.01 | 0.04 | Calpain 1 inhibitor | 0.037 0.015 DBMET00965 | ||
| 0.265 | 0.235 | 0.342 | Caspase 9 stimulant | 0.342 0.152 DBMET00965 | DBMET00965 | |
| 0.083 | 0.054 | 0.083 | Neuropeptide Y antagonist | 0.077 0.064 DBMET00965 | ||
| 0.078 | 0.05 | 0.085 | Sphingosine 1-phosphate receptor antagonist | 0.085 0.037 DBMET00965 | DBMET00965 | |
| 0.049 | 0.021 | 0.05 | Acetyl-CoA carboxylase inhibitor | 0.05 0.021 DBMET00965 | DBMET00965 | |
| 0.145 | 0.117 | 0.196 | Phospholipase C inhibitor | 0.196 0.046 DBMET00965 | DBMET00965 | |
| 0.047 | 0.019 | 0.047 | Substance P antagonist | |||
| 0.07 | 0.043 | 0.07 | Carbonic anhydrase V inhibitor | 0.063 0.05 DBMET00965 | ||
| 0.065 | 0.038 | 0.074 | Caspase 9 inhibitor | 0.074 0.028 DBMET00965 | DBMET00965 | |
| 0.087 | 0.06 | 0.105 | Opioid antagonist | 0.105 0.044 DBMET00965 | DBMET00965 | |
| 0.104 | 0.078 | 0.104 | Nav1.5 sodium channel blocker | |||
| 0.074 | 0.049 | 0.147 | Aminopeptidase I inhibitor | 0.147 0.013 DBMET00965 | DBMET00965 | |
| 0.055 | 0.03 | 0.086 | Urokinase inhibitor | 0.086 0.02 DBMET00965 | DBMET00965 | |
| 0.049 | 0.024 | 0.064 | Oxytocin agonist | 0.064 0.014 DBMET00965 | DBMET00965 | |
| 0.041 | 0.016 | 0.045 | Ceramide glucosyltransferase inhibitor | 0.045 0.011 DBMET00965 | DBMET00965 | |
| 0.074 | 0.05 | 0.093 | Histone deacetylase SIRT2 inhibitor | 0.093 0.034 DBMET00965 | DBMET00965 | |
| 0.061 | 0.037 | 0.124 | Sphingosine kinase inhibitor | 0.124 0.005 DBMET00965 | DBMET00965 | |
| 0.051 | 0.028 | 0.051 | Bombesin antagonist | 0.05 0.029 DBMET00965 | ||
| 0.086 | 0.063 | 0.086 | ATPase (Vacuolar H+) inhibitor | 0.085 0.067 DBMET00965 | ||
| 0.21 | 0.187 | 0.285 | Immunosuppressant | 0.285 0.125 DBMET00965 | DBMET00965 | |
| 0.063 | 0.04 | 0.063 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.054 | 0.031 | 0.066 | Prolyl endopeptidase inhibitor | 0.066 0.018 DBMET00965 | DBMET00965 | |
| 0.084 | 0.061 | 0.09 | Transcription factor NF kappa B stimulant | 0.09 0.051 DBMET00965 | DBMET00965 | |
| 0.067 | 0.044 | 0.112 | Selectin antagonist | 0.112 0.024 DBMET00965 | DBMET00965 | |
| 0.049 | 0.027 | 0.074 | Mannosidase inhibitor | 0.074 0.01 DBMET00965 | DBMET00965 | |
| 0.047 | 0.025 | 0.057 | HIV-1 protease inhibitor | 0.057 0.014 DBMET00965 | DBMET00965 | |
| 0.191 | 0.17 | 0.205 | 5 Hydroxytryptamine uptake stimulant | 0.205 0.141 DBMET00965 | DBMET00965 | |
| 0.063 | 0.043 | 0.063 | Protease activated receptor antagonist | |||
| 0.051 | 0.031 | 0.054 | Collagenase inhibitor | 0.054 0.024 DBMET00965 | DBMET00965 | |
| 0.064 | 0.044 | 0.076 | Beta 3 adrenoreceptor antagonist | 0.076 0.027 DBMET00965 | DBMET00965 | |
| 0.045 | 0.026 | 0.045 | GHS receptor agonist | |||
| 0.056 | 0.038 | 0.063 | Sphingosine 1-phosphate receptor 1 antagonist | 0.063 0.025 DBMET00965 | DBMET00965 | |
| 0.049 | 0.031 | 0.049 | Melanocortin antagonist | 0.048 0.031 DBMET00965 | ||
| 0.029 | 0.012 | 0.035 | Lysophosphatidic acid receptor 1 agonist | 0.035 0.008 DBMET00965 | DBMET00965 | |
| 0.032 | 0.016 | 0.038 | Thrombin receptor antagonist | 0.038 0.012 DBMET00965 | DBMET00965 | |
| 0.027 | 0.011 | 0.027 | Elastase 2 inhibitor | |||
| 0.027 | 0.011 | 0.027 | Elastase 2A inhibitor | |||
| 0.086 | 0.07 | 0.178 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.178 0.02 DBMET00965 | DBMET00965 | |
| 0.031 | 0.015 | 0.036 | Purinergic P2Y15 antagonist | 0.036 0.009 DBMET00965 | DBMET00965 | |
| 0.048 | 0.033 | 0.055 | Aminopeptidase N inhibitor | 0.055 0.028 DBMET00965 | DBMET00965 | |
| 0.208 | 0.193 | 0.325 | Histamine release inhibitor | 0.325 0.111 DBMET00965 | DBMET00965 | |
| 0.048 | 0.033 | 0.078 | Plasmin inhibitor | 0.078 0.022 DBMET00965 | DBMET00965 | |
| 0.023 | 0.009 | 0.028 | Caspase 8 inhibitor | 0.028 0.006 DBMET00965 | DBMET00965 | |
| 0.048 | 0.035 | 0.048 | Carbonic anhydrase XIV inhibitor | 0.044 0.04 DBMET00965 | ||
| 0.04 | 0.027 | 0.04 | Cathepsin L1 inhibitor | |||
| 0.042 | 0.029 | 0.042 | Melanocortin 4 antagonist | 0.041 0.03 DBMET00965 | ||
| 0.027 | 0.014 | 0.027 | Acid ceramidase inhibitor | 0.025 0.019 DBMET00965 | ||
| 0.06 | 0.048 | 0.104 | Glucagon-like peptide 1 agonist | 0.104 0.019 DBMET00965 | DBMET00965 | |
| 0.042 | 0.03 | 0.051 | Growth hormone release inhibitor | 0.051 0.021 DBMET00965 | DBMET00965 | |
| 0.029 | 0.017 | 0.036 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.036 0.009 DBMET00965 | DBMET00965 | |
| 0.057 | 0.045 | 0.095 | Cannabinoid CB1 receptor agonist | 0.095 0.021 DBMET00965 | DBMET00965 | |
| 0.031 | 0.02 | 0.039 | Factor VII inhibitor | 0.039 0.015 DBMET00965 | DBMET00965 | |
| 0.104 | 0.094 | 0.151 | Transcription factor STAT6 inhibitor | 0.151 0.022 DBMET00965 | DBMET00965 | |
| 0.045 | 0.035 | 0.046 | Baculoviral IAP repeat-containing protein inhibitor | 0.046 0.032 DBMET00965 | DBMET00965 | |
| 0.059 | 0.05 | 0.061 | Trypsin inhibitor | 0.061 0.044 DBMET00965 | DBMET00965 | |
| 0.031 | 0.021 | 0.031 | Epoxide hydrolase 1 inhibitor | |||
| 0.079 | 0.07 | 0.088 | Estrogen-related receptor beta agonist | 0.088 0.045 DBMET00965 | DBMET00965 | |
| 0.03 | 0.021 | 0.034 | Caspase 6 inhibitor | 0.034 0.014 DBMET00965 | DBMET00965 | |
| 0.089 | 0.08 | 0.089 | Gastric antisecretory | |||
| 0.027 | 0.018 | 0.027 | Calcium-sensing receptor agonist | |||
| 0.035 | 0.029 | 0.075 | Factor XIIIa inhibitor | 0.075 0.009 DBMET00965 | DBMET00965 | |
| 0.02 | 0.014 | 0.033 | Neurokinin 1 agonist | 0.033 0.009 DBMET00965 | DBMET00965 | |
| 0.048 | 0.042 | 0.125 | Ribonucleoside-diphosphate reductase inhibitor | 0.125 0.015 DBMET00965 | DBMET00965 | |
| 0.05 | 0.045 | 0.05 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.065 | 0.06 | 0.074 | Cathepsin G inhibitor | 0.074 0.049 DBMET00965 | DBMET00965 | |
| 0.028 | 0.024 | 0.038 | Peptide deformylase inhibitor | 0.038 0.015 DBMET00965 | DBMET00965 | |
| 0.051 | 0.047 | 0.063 | DNA helicase inhibitor | 0.063 0.023 DBMET00965 | DBMET00965 | |
| 0.045 | 0.042 | 0.057 | Bombesin 2 receptor antagonist | 0.057 0.026 DBMET00965 | DBMET00965 | |
| 0.13 | 0.127 | 0.13 | Tumour necrosis factor antagonist | |||
| 0.02 | 0.017 | 0.029 | Neuraminidase (Influenza B) inhibitor | 0.029 0.005 DBMET00965 | DBMET00965 | |
| 0.01 | 0.007 | 0.01 | Angiotensin AT2 receptor agonist | |||
| 0.054 | 0.051 | 0.067 | Opioid delta receptor antagonist | 0.067 0.042 DBMET00965 | DBMET00965 | |
| 0.032 | 0.029 | 0.033 | Somatostatin 5 agonist | 0.033 0.026 DBMET00965 | DBMET00965 | |
| 0.082 | 0.079 | 0.175 | Aminopeptidase B inhibitor | 0.175 0.028 DBMET00965 | DBMET00965 | |
| 0.047 | 0.044 | 0.121 | Ribonucleotide reductase inhibitor | 0.121 0.016 DBMET00965 | DBMET00965 | |
| 0.012 | 0.009 | 0.012 | Melatonin 2 antagonist | |||
| 0.02 | 0.018 | 0.02 | Acetyl-CoA carboxylase 2 inhibitor | 0.019 0.018 DBMET00965 | ||
| 0.013 | 0.011 | 0.013 | Melatonin receptor 1A antagonist | |||
| 0.032 | 0.031 | 0.038 | HCV polyprotein inhibitor | 0.038 0.015 DBMET00965 | DBMET00965 | |
| 0.033 | 0.032 | 0.034 | Tryptase inhibitor | 0.034 0.03 DBMET00965 | DBMET00965 | |
| 0.04 | 0.039 | 0.074 | Glycine transporter 2 inhibitor | 0.074 0.019 DBMET00965 | DBMET00965 | |
| 0.038 | 0.037 | 0.094 | Sphingosine kinase 1 inhibitor | 0.094 0.004 DBMET00965 | DBMET00965 | |
| 0.036 | 0.035 | 0.067 | Complement C3a chemotactic receptor antagonist | 0.067 0.019 DBMET00965 | DBMET00965 | |
| 0.033 | 0.032 | 0.036 | Diamine oxidase inhibitor | 0.036 0.028 DBMET00965 | DBMET00965 | |
| 0.049 | 0.049 | 0.055 | Angiotensin-converting enzyme inhibitor | 0.055 0.038 DBMET00965 | DBMET00965 | |
| 0.033 | 0.032 | 0.037 | Bombesin 1 receptor antagonist | 0.037 0.025 DBMET00965 | DBMET00965 | |
| 0.029 | 0.028 | 0.063 | Calcitonin receptor agonist | 0.063 0.014 DBMET00965 | DBMET00965 | |
| 0.012 | 0.012 | 0.013 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.01 DBMET00965 | DBMET00965 | |
| 0.065 | 0.065 | 0.121 | Glutamate dehydrogenase inhibitor | 0.121 0.022 DBMET00965 | DBMET00965 | |
| 0.024 | 0.025 | 0.046 | Bradykinin B2 receptor agonist | 0.046 0.009 DBMET00965 | DBMET00965 | |
| 0.032 | 0.033 | 0.047 | Bradykinin antagonist | 0.047 0.016 DBMET00965 | DBMET00965 | |
| 0.032 | 0.033 | 0.035 | Melanocortin 1 antagonist | 0.035 0.029 DBMET00965 | DBMET00965 | |
| 0.063 | 0.065 | 0.066 | Epoxide hydrolase inhibitor | 0.066 0.059 DBMET00965 | DBMET00965 | |
| 0.078 | 0.081 | 0.101 | Aminoacyl-tRNA synthetase inhibitor | 0.101 0.044 DBMET00965 | DBMET00965 | |
| 0.059 | 0.063 | 0.079 | Histidine decarboxylase inhibitor | 0.079 0.043 DBMET00965 | DBMET00965 | |
| 0.017 | 0.021 | 0.023 | Human T-cell leukemia virus type I protease inhibitor | 0.023 0.013 DBMET00965 | DBMET00965 | |
| 0.03 | 0.035 | 0.047 | Histone deacetylase 7 inhibitor | 0.047 0.019 DBMET00965 | DBMET00965 | |
| 0.056 | 0.062 | 0.066 | Histone deacetylase inhibitor | 0.066 0.045 DBMET00965 | DBMET00965 | |
| 0.023 | 0.03 | 0.036 | Myristoyl transferase inhibitor | 0.036 0.007 DBMET00965 | DBMET00965 | |
| 0.012 | 0.019 | 0.019 | Ileal bile acid transport inhibitor | 0.019 0.01 DBMET00965 | DBMET00965 | |
| 0.016 | 0.024 | 0.019 | Antibiotic Anthracycline-like | 0.019 0.014 DBMET00965 | DBMET00965 | |
| 0.053 | 0.062 | 0.07 | Opioid mu receptor antagonist | 0.07 0.046 DBMET00965 | DBMET00965 | |
| 0.01 | 0.019 | 0.015 | Integrin alphaVbeta6 antagonist | 0.015 0.009 DBMET00965 | DBMET00965 | |
| 0.109 | 0.118 | 0.169 | Cell wall synthesis inhibitor | 0.169 0.048 DBMET00965 | DBMET00965 | |
| 0.037 | 0.047 | 0.039 | Cathepsin F inhibitor | 0.039 0.037 DBMET00965 | DBMET00965 | |
| 0.055 | 0.065 | 0.066 | Beta adrenoreceptor antagonist | 0.066 0.044 DBMET00965 | DBMET00965 | |
| 0.019 | 0.03 | 0.045 | Bradykinin B2 receptor antagonist | 0.045 0.011 DBMET00965 | DBMET00965 | |
| 0.075 | 0.086 | 0.082 | CC chemokine 5 receptor agonist | 0.082 0.057 DBMET00965 | DBMET00965 | |
| 0.024 | 0.036 | 0.041 | Lysophosphatidic acid 2 receptor antagonist | 0.041 0.012 DBMET00965 | DBMET00965 | |
| 0.036 | 0.048 | 0.047 | AICAR transformylase inhibitor | 0.047 0.026 DBMET00965 | DBMET00965 | |
| 0.08 | 0.092 | 0.12 | Mediator release inhibitor | 0.12 0.047 DBMET00965 | DBMET00965 | |
| 0.12 | 0.134 | 0.126 | Interferon gamma antagonist | 0.126 0.119 DBMET00965 | DBMET00965 | |
| 0.028 | 0.043 | 0.032 | Growth factor receptor-bound protein 2 antagonist | 0.032 0.031 DBMET00965 | DBMET00965 | |
| 0.027 | 0.042 | 0.036 | Cathepsin L2 inhibitor | 0.036 0.031 DBMET00965 | DBMET00965 | |
| 0.086 | 0.101 | 0.098 | Nav1.4 sodium channel blocker | 0.098 0.079 DBMET00965 | DBMET00965 | |
| 0.031 | 0.047 | 0.042 | Macrophage elastase inhibitor | 0.042 0.031 DBMET00965 | DBMET00965 | |
| 0.044 | 0.062 | 0.059 | CXC chemokine 4 receptor antagonist | 0.059 0.043 DBMET00965 | DBMET00965 | |
| 0.105 | 0.125 | 0.174 | Neurotrophic factor | 0.174 0.041 DBMET00965 | DBMET00965 | |
| 0.009 | 0.029 | 0.014 | CXC chemokine 4 receptor agonist | 0.014 0.013 DBMET00965 | DBMET00965 | |
| 0.01 | 0.03 | 0.02 | KiSS-1 receptor antagonist | 0.02 0.009 DBMET00965 | DBMET00965 | |
| 0.045 | 0.066 | 0.065 | Carbonic anhydrase stimulant | 0.065 0.036 DBMET00965 | DBMET00965 | |
| 0.035 | 0.056 | 0.04 | DNA gyrase subunit A inhibitor | 0.04 0.035 DBMET00965 | DBMET00965 | |
| 0.045 | 0.068 | 0.068 | Botulinum neurotoxin type A inhibitor | 0.068 0.027 DBMET00965 | DBMET00965 | |
| 0.029 | 0.052 | 0.041 | Membrane dipeptidase inhibitor | 0.041 0.026 DBMET00965 | DBMET00965 | |
| 0.181 | 0.204 | 0.281 | Antithrombotic | 0.281 0.102 DBMET00965 | DBMET00965 | |
| 0.015 | 0.039 | 0.028 | Follicle-stimulating hormone antagonist | 0.028 0.005 DBMET00965 | DBMET00965 | |
| 0.041 | 0.065 | 0.046 | CD45 antagonist | 0.046 0.044 DBMET00965 | DBMET00965 | |
| 0.02 | 0.044 | 0.027 | Trypsin II inhibitor | 0.027 0.024 DBMET00965 | DBMET00965 | |
| 0.092 | 0.116 | 0.162 | Bone formation stimulant | 0.162 0.05 DBMET00965 | DBMET00965 | |
| 0.09 | 0.115 | 0.111 | Cell adhesion inhibitor | 0.111 0.073 DBMET00965 | DBMET00965 | |
| 0.091 | 0.116 | 0.139 | Aldehyde dehydrogenase inhibitor | 0.139 0.054 DBMET00965 | DBMET00965 | |
| 0.011 | 0.038 | 0.02 | Growth hormone releasing factor antagonist | 0.02 0.019 DBMET00965 | DBMET00965 | |
| 0.015 | 0.044 | 0.019 | Toll-Like receptor 8 agonist | 0.019 0.017 DBMET00965 | DBMET00965 | |
| 0.118 | 0.149 | 0.183 | Psychostimulant | 0.183 0.091 DBMET00965 | DBMET00965 | |
| 0.012 | 0.043 | 0.038 | Follicle-stimulating hormone agonist | 0.038 0.008 DBMET00965 | DBMET00965 | |
| 0.019 | 0.05 | 0.027 | Integrin alpha2beta1 antagonist | 0.027 0.017 DBMET00965 | DBMET00965 | |
| 0.105 | 0.139 | 0.143 | Sphingosine 1-phosphate receptor 2 antagonist | 0.143 0.051 DBMET00965 | DBMET00965 | |
| 0.042 | 0.078 | 0.06 | Sphingosine 1-phosphate receptor 3 antagonist | 0.06 0.038 DBMET00965 | DBMET00965 | |
| 0.127 | 0.163 | 0.188 | Succinate dehydrogenase inhibitor | 0.188 0.06 DBMET00965 | DBMET00965 | |
| 0.081 | 0.119 | 0.096 | Folate antagonist | 0.096 0.073 DBMET00965 | DBMET00965 | |
| 0.096 | 0.136 | 0.126 | Sphingosine 1-phosphate receptor 4 antagonist | 0.126 0.063 DBMET00965 | DBMET00965 | |
| 0.025 | 0.066 | 0.036 | Integrin alpha2 antagonist | 0.036 0.027 DBMET00965 | DBMET00965 | |
| 0.028 | 0.07 | 0.036 | Histone deacetylase 9 inhibitor | 0.036 0.034 DBMET00965 | DBMET00965 | |
| 0.052 | 0.098 | 0.066 | Beta 2 adrenoreceptor agonist | 0.066 0.028 DBMET00965 | DBMET00965 | |
| 0.096 | 0.145 | 0.137 | Diuretic | 0.137 0.088 DBMET00965 | DBMET00965 | |
| 0.014 | 0.064 | 0.031 | Sirtuin 2 inhibitor | 0.031 0.024 DBMET00965 | DBMET00965 | |
| 0.067 | 0.117 | 0.131 | UDP-glucose 4-epimerase inhibitor | 0.131 0.037 DBMET00965 | DBMET00965 | |
| 0.038 | 0.089 | 0.056 | Cyclin A1 inhibitor | 0.056 0.048 DBMET00965 | DBMET00965 | |
| 0.012 | 0.064 | 0.037 | Arginase inhibitor | 0.037 0.025 DBMET00965 | DBMET00965 | |
| 0.076 | 0.128 | 0.096 | Protein kinase C gamma inhibitor | 0.096 0.084 DBMET00965 | DBMET00965 | |
| 0.158 | 0.211 | 0.199 | Gastrin inhibitor | 0.199 0.15 DBMET00965 | DBMET00965 | |
| 0.079 | 0.133 | 0.113 | DOPA decarboxylase inhibitor | 0.113 0.054 DBMET00965 | DBMET00965 | |
| 0.142 | 0.197 | 0.167 | 5 Hydroxytryptamine release stimulant | 0.167 0.157 DBMET00965 | DBMET00965 | |
| 0.08 | 0.135 | 0.123 | CDC-like kinase 3 inhibitor | 0.123 0.04 DBMET00965 | DBMET00965 | |
| 0.067 | 0.122 | 0.083 | Polo-like kinase-1 inhibitor | 0.083 0.076 DBMET00965 | DBMET00965 | |
| 0.076 | 0.132 | 0.101 | Adenylate kinase inhibitor | 0.101 0.066 DBMET00965 | DBMET00965 | |
| 0.031 | 0.088 | 0.083 | Alcohol oxidase inhibitor | 0.083 0.023 DBMET00965 | DBMET00965 | |
| 0.009 | 0.066 | 0.031 | Nociceptin (N/OFQ) receptor antagonist | 0.031 0.028 DBMET00965 | DBMET00965 | |
| 0.134 | 0.197 | 0.166 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.166 0.115 DBMET00965 | DBMET00965 | |
| 0.029 | 0.092 | 0.053 | Acyl-CoA dehydrogenase inhibitor | 0.053 0.039 DBMET00965 | DBMET00965 | |
| 0.103 | 0.168 | 0.206 | Platelet adhesion inhibitor | 0.206 0.068 DBMET00965 | DBMET00965 | |
| 0.028 | 0.094 | 0.041 | Glucagon-like peptide 1 receptor antagonist | 0.041 0.024 DBMET00965 | DBMET00965 | |
| 0.024 | 0.09 | 0.056 | Thymidylate synthase inhibitor | 0.056 0.021 DBMET00965 | DBMET00965 | |
| 0.097 | 0.164 | 0.137 | Arachidonic acid antagonist | 0.137 0.104 DBMET00965 | DBMET00965 | |
| 0.02 | 0.096 | 0.039 | GABA uptake inhibitor | 0.039 0.028 DBMET00965 | DBMET00965 | |
| 0.039 | 0.124 | 0.093 | Glutamate decarboxylase inhibitor | 0.093 0.034 DBMET00965 | DBMET00965 | |
| 0.118 | 0.203 | 0.136 | Ca2+-transporting ATPase inhibitor | 0.136 0.091 DBMET00965 | DBMET00965 | |
| 0.02 | 0.106 | 0.073 | Ornithine carbamoyltransferase inhibitor | 0.073 0.024 DBMET00965 | DBMET00965 | |
| 0.117 | 0.203 | 0.168 | Spasmolytic | 0.168 0.147 DBMET00965 | DBMET00965 | |
| 0.062 | 0.149 | 0.094 | Anabolic | 0.094 0.071 DBMET00965 | DBMET00965 | |
| 0.034 | 0.126 | 0.113 | Phenylalanine 4-hydroxylase inhibitor | 0.113 0.02 DBMET00965 | DBMET00965 | |
| 0.061 | 0.157 | 0.145 | Adenylate cyclase inhibitor | 0.145 0.048 DBMET00965 | DBMET00965 | |
| 0.027 | 0.128 | 0.07 | Carbamoyl phosphate synthetase inhibitor | 0.07 0.034 DBMET00965 | DBMET00965 | |
| 0.022 | 0.124 | 0.083 | NMDA 2C receptor antagonist | 0.083 0.023 DBMET00965 | DBMET00965 | |
| 0.031 | 0.134 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.037 DBMET00965 | DBMET00965 | |
| 0.055 | 0.159 | 0.111 | Triose-phosphate isomerase inhibitor | 0.111 0.038 DBMET00965 | DBMET00965 | |
| 0.055 | 0.163 | 0.13 | Ferrochelatase inhibitor | 0.13 0.047 DBMET00965 | DBMET00965 | |
| 0.029 | 0.151 | 0.058 | Sphingosine kinase 2 inhibitor | 0.058 0.034 DBMET00965 | DBMET00965 | |
| 0.082 | 0.21 | 0.121 | Hexokinase inhibitor | 0.121 0.117 DBMET00965 | DBMET00965 | |
| 0.049 | 0.184 | 0.111 | GABA C receptor agonist | 0.111 0.056 DBMET00965 | DBMET00965 | |
| 0.052 | 0.187 | 0.083 | NADH dehydrogenase inhibitor | 0.083 0.069 DBMET00965 | DBMET00965 | |
| 0.046 | 0.183 | 0.084 | HIV-1 integrase (Overall Integration) inhibitor | 0.084 0.072 DBMET00965 | DBMET00965 | |
| 0.047 | 0.231 | 0.075 | MAP kinase kinase 7 inhibitor | 0.075 0.063 DBMET00965 | DBMET00965 | |
| 0.077 | 0.264 | 0.182 | Aldehyde oxidase inhibitor | 0.182 0.115 DBMET00965 | DBMET00965 | |
| 0.061 | 0.256 | 0.104 | Interleukin 8 antagonist | 0.104 0.088 DBMET00965 | DBMET00965 | |
| 0.037 | 0.235 | 0.101 | Creatine kinase inhibitor | 0.101 0.058 DBMET00965 | DBMET00965 | |
| 0.123 | 0.325 | 0.219 | Sodium/bile acid cotransporter inhibitor | 0.219 0.163 DBMET00965 | DBMET00965 | |
| 0.029 | 0.34 | 0.076 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.076 0.071 DBMET00965 | DBMET00965 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |